Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition.
Osbelt L, Wende M, Almási É, Derksen E, Muthukumarasamy U, Lesker TR, Galvez EJC, Pils MC, Schalk E, Chhatwal P, Färber J, Neumann-Schaal M, Fischer T, Schlüter D, Strowig T. Osbelt L, et al. Among authors: schalk e. Cell Host Microbe. 2021 Nov 10;29(11):1663-1679.e7. doi: 10.1016/j.chom.2021.09.003. Epub 2021 Oct 4. Cell Host Microbe. 2021. PMID: 34610293 Free article.
Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.
Hentrich M, Böll B, Teschner D, Panse J, Schmitt T, Naendrup JH, Schmidt-Hieber M, Neitz J, Fiegle E, Schalk E. Hentrich M, et al. Among authors: schalk e. Infection. 2023 Aug;51(4):1153-1159. doi: 10.1007/s15010-023-02029-4. Epub 2023 Apr 4. Infection. 2023. PMID: 37016194
Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Teschner D, Berisha M, Panse J, Schmitt T, Fiegle E, Naendrup JH, Neitz J, Schmidt-Hieber M, Hentrich M, Böll B, Schalk E. Teschner D, et al. Among authors: schalk e. Eur J Haematol. 2023 Dec;111(6):914-921. doi: 10.1111/ejh.14098. Epub 2023 Sep 13. Eur J Haematol. 2023. PMID: 37705250
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial.
Grünwald V, Pink D, Egerer G, Schalk E, Augustin M, Deinzer CKW, Kob V, Reichert D, Kebenko M, Brandl S, Hahn D, Lindner LH, Hoiczyk M, Ringsdorf U, Hanker LC, Hempel D, De Rivas B, Wismann T, Ivanyi P. Grünwald V, et al. Among authors: schalk e. Cancers (Basel). 2022 Oct 25;14(21):5234. doi: 10.3390/cancers14215234. Cancers (Basel). 2022. PMID: 36358652 Free PMC article.
Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literature.
Wolleschak D, Schalk E, Krogel C, Schnoeder TM, Luehr H, Jentsch-Ullrich K, Fischer T, Heidel FH. Wolleschak D, et al. Among authors: schalk e. J Hematol Oncol. 2013 Jun 11;6:39. doi: 10.1186/1756-8722-6-39. J Hematol Oncol. 2013. PMID: 23759001 Free PMC article. Review.
97 results